tiprankstipranks
Tevogen Bio Holdings (TVGN)
NASDAQ:TVGN
US Market

Tevogen Bio Holdings (TVGN) Financial Statements

Compare
268 Followers

Tevogen Bio Holdings Financial Overview

Tevogen Bio Holdings's market cap is currently $247.70M. The company's EPS TTM is $-0.389; its P/E ratio is ―; Tevogen Bio Holdings is scheduled to report earnings on April 30, 2025, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 0.00$ 0.00$ 0.00
Gross Profit$ 0.00$ 0.00$ 0.00
Operating Income-$ -13.72M$ -4.62M
EBITDA$ 188.71K$ -953.08K$ -28.75K
Net Income$ -67.33K$ 4.41M$ -15.60M
Balance Sheet
Cash & Short-Term Investments$ 8.84K$ 129.19K$ 7.12M
Total Assets$ 17.04M$ 357.14M$ 7.66M
Total Debt$ 1.63M$ 40.01M$ 23.48M
Net Debt$ 1.62M$ 39.88M$ 16.36M
Total Liabilities$ 17.73M$ 15.06M$ 24.15M
Stockholders' Equity$ -695.80K$ 342.08M$ -16.49M
Cash Flow
Free Cash Flow$ -1.38M$ -694.44K$ -5.38M
Operating Cash Flow$ -1.38M$ -215.40K$ -5.27M
Investing Cash Flow$ 342.92M-$ -109.73K
Financing Cash Flow$ -341.66M$ 7.50K$ 12.50M
Currency in USD

Tevogen Bio Holdings Earnings and Revenue History

Tevogen Bio Holdings Debt to Assets

Tevogen Bio Holdings Cash Flow

Tevogen Bio Holdings Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis